Modulation of a fibrotic process induced by transforming growth factor beta-1 in dermal equivalents.
Why initially normal wound healing sometimes shifts toward an impaired cicatrization is poorly understood. Collagen gels with incorporated fibroblasts constitute valuable in vitro models to study mechanisms of connective tissue reorganization. Such 1-week-old, partially contracted normal dermal equivalents were treated with concentrations of TGF-beta1 ranging from 1 to 10 ng/ml. The cytokine was applied in a single dose or four times at regular intervals, over a 2-week period. Dose-dependent activation of fibroblasts was observed after treatment. The cytokine induced a myofibroblastic transformation of dermal cells, significantly enhanced the process of dermal contraction, and stimulated synthesis of such proteins as cellular fibronectin, tenascin and smooth-muscle actin. Our approach is more informative than models using pathological or pretreated dermal cells, since it demonstrates newly induced modulation of fibrotic transformation in an initially normal dermal equivalent. This in vitro assay will enable us to study mechanisms involved in the shift between normal and impaired fibrotic transformation during wound healing.
Gentilhomme
E
E
Radiobiology Department, CRSSA, La Tronche, France.
Neveux
Y
Y
Lebeau
J
J
Desmouliere
A
A
Bergier
J
J
Schmitt
D
D
Haftek
M
M
D000328:Adult; D002454:Cell Differentiation / Q000187:drug effects*; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D005347:Fibroblasts / Q000166:cytology / Q000502:physiology / Q000648:ultrastructure; D005353:Fibronectins / Q000096:biosynthesis; D006801:Humans; D020033:Protein Isoforms / Q000494:pharmacology; D012867:Skin / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D019063:Tenascin / Q000096:biosynthesis; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
D005353:Fibronectins; D020033:Protein Isoforms; D019063:Tenascin; D016212:Transforming Growth Factor beta